Literature DB >> 7929697

Salivary defense factors and oral health in patients with common variable immunodeficiency.

V Kirstilä1, J Tenovuo, O Ruuskanen, J Nikoskelainen, K Irjala, P Vilja.   

Abstract

Studies of oral health in patients with common variable immunodeficiency have given controversial results. Obviously, one major factor modifying the oral health of these patients is saliva, in which the antibody-mediated defense is remarkably impaired compared to that of healthy subjects. However, the occurrence of nonimmunoglobulin (innate) antimicrobial agents in saliva of these patients is virtually unknown. Therefore, we analyzed both immune (total IgA, IgG, IgM, anti-Streptococcus mutans IgA, IgG, and IgM antibodies) and nonimmune (lysozyme, lactoferrin, salivary peroxidase, myeloperoxidase, hypothiocyanite, thiocyanate, and agglutinins) factors in whole saliva of 15 patients with common variable immunodeficiency. All patients were on Ig-replacement therapy (median duration, 10 years; range, 2-25 years), which had normalized their IgG but not their IgA or IgM levels both in serum and in saliva. Also, comprehensive clinical and microbiological analyses were made. The control group comprised 15 age- and sex-matched immunologically healthy subjects. The results showed no notable differences in dental caries, periodontal diseases, or salivary microorganisms but the patients had a history of more frequent oral mucosal lesions and respiratory infections. All innate, nonimmune salivary defense factors were equally abundant in the patients as in the controls, in many cases even at somewhat higher concentrations. These findings suggest that in spite of immunodeficiency, patients with common variable immunodeficiency display normal, perhaps even slightly elevated, levels of nonimmunoglobulin defense factors in whole saliva.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929697     DOI: 10.1007/bf01552309

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  38 in total

1.  Oral conditions in individuals with selective immunoglobulin A deficiency and common variable immunodeficiency.

Authors:  G N Engström; P E Engström; L Hammarström; C I Smith
Journal:  J Periodontol       Date:  1992-12       Impact factor: 6.993

2.  Antimicrobial factors of saliva in relation to dental caries and salivary levels of mutans streptococci.

Authors:  J Tenovuo; H Jentsch; T Soukka; L Karhuvaara
Journal:  J Biol Buccale       Date:  1992-06

3.  Antibodies to indigenous and laboratory strains of Streptococcus mutans in saliva from children with dental caries and from caries-free children.

Authors:  G R Riviere; L Papagiannoulis
Journal:  Pediatr Dent       Date:  1987-09       Impact factor: 1.874

Review 4.  Drugs and the periodontium.

Authors:  R A Seymour; P A Heasman
Journal:  J Clin Periodontol       Date:  1988-01       Impact factor: 8.728

5.  Longitudinal study of relations between human salivary antimicrobial proteins and measures of dental plaque accumulation and composition.

Authors:  J D Rudney; M A Krig; E K Neuvar
Journal:  Arch Oral Biol       Date:  1993-05       Impact factor: 2.633

6.  Immunodeficiency disease and dental caries in man.

Authors:  D W Legler; J R McGhee; D P Lynch; J F Mestecky; M E Schaefer; J Carson; E L Bradley
Journal:  Arch Oral Biol       Date:  1981       Impact factor: 2.633

Review 7.  Immunobiology of dental caries: microbial aspects and local immunity.

Authors:  J R McGhee; S M Michalek
Journal:  Annu Rev Microbiol       Date:  1981       Impact factor: 15.500

8.  Periodontal status of patients with abnormalities of the immune system. II. Observations over a 2-year period.

Authors:  P B Robertson; B F Mackler; T E Wright; B M Levy
Journal:  J Periodontol       Date:  1980-02       Impact factor: 6.993

9.  Effect of calcium on reactions between a salivary agglutinin and a serotype c strain of Streptococcus mutans.

Authors:  J Rundegren; T Ericson
Journal:  J Oral Pathol       Date:  1981-08

10.  Immunoglobulin A antibodies reactive with Streptococcus mutans in saliva of adults, children, and predentate infants.

Authors:  L L Bammann; R J Gibbons
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

View more
  4 in total

1.  Clinical trials of yeast-derived β-(1,3) glucan in children: effects on innate immunity.

Authors:  Josef Richter; Vladimir Svozil; Vlastimil Král; Lucie Rajnohová Dobiášová; Ivana Stiborová; Vaclav Vetvicka
Journal:  Ann Transl Med       Date:  2014-02

2.  Placebo-driven clinical trials of yeast-derived β-(1-3) glucan in children with chronic respiratory problems.

Authors:  Vaclav Vetvicka; Josef Richter; Vladimir Svozil; Lucie Rajnohová Dobiášová; Vlastimil Král
Journal:  Ann Transl Med       Date:  2013-10

3.  Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.

Authors:  Y H Samaranayake; L P Samaranayake; E H Pow; V T Beena; K W Yeung
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

Review 4.  Oral microbial ecology and the role of salivary immunoglobulin A.

Authors:  H Marcotte; M C Lavoie
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.